Current and future treatment modalities for hepatocellular carcinoma.

D. Farmer,P. Seu,K. Swenson,J. Economou,R. Busuttil

DOI: https://doi.org/10.1016/S1089-3261(05)70276-2

1997-08-01

Clinical Liver Disease

Abstract:

What problem does this paper attempt to address?

Identification of a Novel Homozygous Mutation in the MYO15A Gene in a Kazakh Family with Non-Syndromic Hearing Loss

Hongbin Zhou,Ahan Kuermanhan,Zhihua Zhang,Wenjing Wang,Jie Dong,Zhou,Jian Mu,Lin Zhao,Jian Wang,Bing Li,Biaobang Chen

DOI: https://doi.org/10.1016/j.ijporl.2019.06.018

IF: 1.626

2019-01-01

International Journal of Pediatric Otorhinolaryngology

Abstract:BACKGROUND:Millions of people around the world are plagued by hearing loss. More than 50% of congenital or pre-lingual deafness is associated with genetic factors and has highly genetic heterogeneity. To date, although hundreds of genes have been found to be implicated in non-syndromic deafness, there are still lots of genes or loci that we need to verify.METHODS:In this study, we performed target sequencing and Sanger sequencing in a Kazakh consanguineous family with autosomal recessive non-syndromic hearing loss. Following that, functional and structural studies predicted the pathogenic effect of novel mutations by use of the online tools.RESULTS:We identified a novel homozygous mutation p.R3191C in MYO15A gene causing deafness in this family. The mutation p.R3191C co-segregated with the disease phenotype in this family and was not present in any public databases. Automatic tools predict that the novel mutation makes a great impact on the function and structure of MYO15A protein.CONCLUSIONS:This is a novel mutation of MYO15A causing deafness and also the first report of MYO15A mutations causing deafness in the Kazakh families. This finding expanded the spectrum of MYO15A mutations, making it more precise for future genetic diagnosis in patients with deafness.
A Novel Mutation Located in the N-Terminal Domain of MYO15A Caused Sensorineural Hearing Loss.

Yanli Wang,Zengping Liu,Yong Li,Zhipeng Nie,Baicheng Xu,Yiming Zhu,Shihong Duan,Xingjian Chen,Huan Tan,Jiong Dang,Minxin Guan,Yufen Guo

DOI: https://doi.org/10.1002/mgg3.70042

2024-01-01

Molecular Genetics & Genomic Medicine

Abstract:BACKGROUND:MYO15A is one of the common genes of severe-to-profound sensorineural deafness. Mutations in this gene can cause both pre- and post-lingual hearing losses. In this study, a novel MYO15A variant (c.2482C>T) was identified to be associated with autosomal recessive non-syndromic hearing loss (ARNSHL) in a Chinese Uighur family. METHODS:To examine the effects of the MYO15A mutation on the morphology and function of the derived hair cell-like cells, two iPSCs were generated separately from the proband and a mutation-negative family member and those were then induced to hair cell-like cells. RESULTS:Results showed that this homozygous MYO15A mutation (PVS1 + PM2 + PP1 + PP3), which is located in the N-terminal domain, displayed significant differences in the morphology and function of hair cell-like cells between the proband and the normal control, although it had no effect on the totipotency of iPSCs. CONCLUSION:Our study demonstrates that the novel variant c.2482C>T in the MYO15A gene may cause inner ear hair cell dysfunction and audiological disorders in this family.
Maternally inherited hearing loss is associated with the novel mitochondrial tRNASer(UCN) 7505T>C mutation in a Han Chinese family

Xiaowen Tang,Ronghua Li,Jing Zheng,Qin Cai,Ting Zhang,Shasha Gong,Wuwei Zheng,Xiumei He,Yi Zhu,Ling Xue,Aifen Yang,Li Yang,Jianxin Lu,Min-Xin Guan

DOI: https://doi.org/10.1016/j.ymgme.2010.01.008

IF: 4.204

2010-01-01

Molecular Genetics and Metabolism

Abstract:Mutations in mitochondrial DNA (mtDNA) have been found to be one of the most important causes of sensorineural hearing loss. We report here a clinical, genetic, molecular and biochemical characterization of a Han Chinese pedigree with maternally transmitted nonsyndromic hearing impairment. Seven of nine matrilineal relatives exhibited a variable severity and age-at-onset (8years old) of hearing loss. Mutational analysis of mtDNA identified the novel homoplasmic tRNASer(UCN) 7505T>C mutation and other 37 variants belonging to haplogroup F1. The 7505T>C mutation, which is absent in 449 Chinese controls, is located at a highly conserved base-pairing (10A–20U) of tRNASer(UCN). The abolishment of 10A–20U base-pairing likely alters the tRNASer(UCN) metabolism. Functional significant of this mutation was supported by ∼65% reductions in the level of tRNASer(UCN) observed in the lymphoblastoid cell lines carrying the 7505T>C mutation, compared with the wild-type cell lines. This reduced tRNA level is below the proposed threshold to support a normal respiration in lymphoblastoid cells. Furthermore, the highly conserved tRNAAla 5587T>C and Cytb C93Y variants may have a modifying role of deafness expression associated with the 7505T>C mutation. However, genotyping analysis of nuclear modifier gene TRMU and the prominent deafness-cause gene GJB2 failed to detect any mutations in the member of this family. These data strongly indicate that the novel tRNASer(UCN) 7505T>C mutation is involved in maternally transmitted hearing loss. However, other genetic, epigenetic or environmental factors may contribute to the phenotypic variability of this family. Our findings will be helpful for counseling families of maternally inherited hearing loss.
Clinical Evaluation And Sequence Analysis Of The Complete Mitochondrial Genome Of Three Chinese Patients With Hearing Impairment Associated With The 12s Rrna T1095c Mutation

Ld Zhao,Wy Young,R Li,Qj Wang,Yp Qian,Mx Guan

DOI: https://doi.org/10.1016/j.bbrc.2004.10.199

IF: 3.1

2004-01-01

Biochemical and Biophysical Research Communications

Abstract:Mutations in mitochondrial DNA (mtDNA), particularly those in the 12S rRNA gene, have been shown to be associated with sensorineural hearing loss. Here we report the clinical and sequence analysis of the entire mitochondrial genome in three Chinese subjects with aminoglycoside-induced and non-syndromic hearing impairment. Clinical evaluation showed a variable phenotype of hearing impairment including the age of onset and audiometric configuration in these subjects. Sequence analysis of the complete mitochondrial genomes in three subjects showed the distinct sets of mtDNA polymorphism, in addition to the identical mitochondrial 12S rRNA T1095C mutation. This mutation was previously identified to be associated with hearing impairment in three families from different genetic backgrounds. The T1095C mutation was absent in 364 Chinese control. In fact, the occurrence of the T1095C mutation in these several genetically unrelated subjects affected by hearing impairment strongly indicates that this mutation is involved in the pathogenesis of hearing impairment. Among other nucleotide changes, the A2238G and T2885C mutations in the 16S rRNA, the I175V mutation in the CO2, the F16L mutation in the A6 and the V112M mutation in the ND6 exhibited a high evolutionary conservation. These data suggest that the T1095C mutation may be associated with aminoglycoside-induced and non-syndromic hearing impairments and A2238G and T2885C mutations in the 16S rRNA, the I175V mutation in the CO2, the F16L mutation in the A6 and the V112M mutation in the ND6 may contribute to the phenotypic expression of the T1095C mutation in these subjects. (C) 2004 Elsevier Inc. All rights reserved.
Cosegregation of C-Insertion at Position 961 with the A1555g Mutation of the Mitochondrial 12s Rrna Gene in A Large Chinese Family with Maternally Inherited Hearing Loss

RH Li,GQ Xing,M Yan,X Cao,XZ Liu,XK Bu,MX Guan

DOI: https://doi.org/10.1002/ajmg.a.20305

2003-01-01

American Journal of Medical Genetics Part A

Abstract:Mutations in the mitochondrial DNA have been shown to be one of the most important causes of sensorineural hearing loss. Here, we report the characterization of a large Chinese family (507 members in six generations) with maternally inherited non-syndromic hearing loss. Members of this family showed variable severity and age-of-onset of hearing impairment. In particular, the average age at onset of hearing loss in this family changed from 49 years (generation III) to 3 years (generation VI). Sequence analysis of the complete mitochondrial genome in this pedigree revealed the presence of a homoplasmic A1555G mutation in the 12S rRNA gene and other nucleotide changes. Of these changes, a C insertion at position 961 in the 12S rRNA gene is of special interest as mutations at this position have been found to be associated with aminoglycoside induced deafness in several genetically unrelated families. These data imply that the C insertion at position 961 in the 12S rRNA gene, acting as a secondary factor, could play a role in the phenotypic expression of the deafness associated A1555G mutation.
Maternally Inherited Aminoglycoside-Induced and Nonsyndromic Hearing Loss is Associated with the 12S Rrna C1494T Mutation in Three Han Chinese Pedigrees.

Jianfu Chen,Li Yang,Alfen Yang,Yi Zhu,Jianyue Zhao,Dongmei Sun,Zhlhua Tao,Xiaowen Tang,Jindan Wang,Xinjian Wang,Asami Tsushima,Jinshan Lan,Weixing Li,Fangli Wu,Qian Yuan,Jingzhang Ji,Jinbao Feng,Chunli Wu,Zhisu Liao,Zhiyuan Li,John H. Greinwald,Jianxin Lu,Min-Xin Guan

DOI: https://doi.org/10.1016/j.gene.2007.06.009

IF: 3.913

2007-01-01

Gene

Abstract:We report here the clinical, genetic and molecular characterization of three Han Chinese pedigrees with maternally transmitted aminoglycoside-induced and nonsyndromic bilateral hearing loss. Clinical evaluation revealed the wide range of severity, age-at-onset and audiometric configuration of hearing impairment in matrilineal relatives in these families. The penetrances of hearing loss in these pedigrees were 28%, 20%, and 15%, with an average of 21%, when aminoglycoside-induced deafness was included. When the effect of aminoglycosides was excluded, the penetrances of hearing loss in these seven pedigrees were 21%, 13% and 8%, with an average of 14%. Sequence analysis of the complete mitochondrial genomes in these pedigrees showed the presence of the deafness-associated 12S rRNA C1494T mutation, in addition to distinct sets of mtDNA polymorphism belonging to Eastern Asian haplogroups F1a1, F1a1 and D5a2, respectively. This suggested that the C1494T mutation occurred sporadically and multiplied through evolution of the mtDNA. The absence of functionally significant mutations in tRNA and rRNAs or secondary LHON mutations in their mtDNA suggests that these mtDNA haplogroup-specific variants may not play an important role in the phenotypic expression of the C1494T mutation in those Chinese families. In addition, the lack of significant mutation in the GJB2 gene ruled out the possible involvement of GJB2 in the phenotypic expression of the C1494T mutation in those affected subjects. However, aminoglycosides and other nuclear modifier genes play a modifying role in the phenotypic manifestation of the C1494T mutation in these Chinese families.
Extremely Low Penetrance of Deafness Associated with the Mitochondrial 12S Rrna T1095C Mutation in Three Chinese Families.

Pu Dai,Yongyi Yuan,Deliang Huang,Yaping Qian,Xin Liu,Dongyi Han,Huijun Yuan,Xinjiang Wang,Wie-Yen Young,Min-Xin Guan

DOI: https://doi.org/10.1016/j.bbrc.2006.07.031

IF: 3.1

2006-01-01

Biochemical and Biophysical Research Communications

Abstract:Mutations in mitochondrial DNA (mtDNA) have been found to be associated with sensorineural hearing loss. We report here the clinical, genetic, and molecular characterization of three Chinese pedigrees (a total of 43 matrilineal relatives) with aminoglycoside-induced impairment. Clinical evaluation revealed the variable phenotype of hearing impairment including audiometric configuration in these subjects, although these subjects shared some common features: being bilateral and sensorineural hearing impairment. Strikingly, only probands of these Chinese pedigrees exhibited severe to profound hearing loss. Mutational analysis of the mtDNA in these pedigrees showed the presence of homoplasmic 12S rRNA T1095C mutation, which has been associated with hearing impairment in several families. Sequence analysis of the complete mitochondrial genomes in these pedigrees showed the identical homoplasmic T1095C mutation and distinct sets of mitochondrial DNA (mtDNA) variants belonging to haplogroups M11C. Despite the presence of several highly evolutionarily conservative variants in protein-encoding genes and 16S rRNA gene, the extremely low penetrance of hearing loss with the T1095C mutation implies that the mitochondrial variants may not play an important role in the phenotypic expression of the T1095C mutation in these Chinese families. However, the history of exposure to aminoglycosides in these three hearing-impaired subjects suggested that the aminoglycosides very likely are the cause of hearing loss.
Mutations at position 7445 in the precursor of mitochondrial tRNASer(UCN) gene in three maternal Chinese pedigrees with sensorineural hearing loss

Jing Chen,Huijun Yuan,Jianxin Lu,Xin Liu,Guojian Wang,Yi Zhu,Jing Cheng,Xinjian Wang,Bing Han,Li Yang,Shuzhi Yang,Aifeng Yang,Qing Sun,Dongyang Kang,Xin Zhang,Pu Dai,Suoqiang Zhai,Dongyi Han,Wie-Yen Young,Min-Xin Guan

DOI: https://doi.org/10.1016/j.mito.2008.05.002

IF: 4.534

2008-01-01

Mitochondrion

Abstract:We report here the clinical, genetic and molecular characterization of three Chinese pedigrees with nonsyndromic bilateral hearing loss. Clinical and genetic evaluations revealed the variable severity and age-of-onset in hearing impairment in these families. Strikingly, there were extremely low penetrances of hearing impairment in these Chinese families. Sequence analysis of the complete mitochondrial DNA (mtDNA) showed the known A7445C mutation in two pedigrees and the novel A7445T mutation in another pedigree, in addition to distinct sets of mtDNA polymorphisms belong to Asian haplogroups D4j and F4. Indeed, the A7445C or A7445T mutation in the CO1 and the precursor of tRNASer(UCN) genes was present in homoplasmy only in the maternal lineage of those pedigrees but not other members of these families and 164 Chinese controls. In fact, the A7445C or A7445T mutation results in a read-through of the stop condon AGA of the CO1 message on the H strand of mtDNA, thereby adding three amino acids (Ser-Gln-Lys) to the C-terminal of the polypeptide. However, the mutated polypeptide may retain a partial function. Alternatively, the A7445C or A7445T mutation is adjacent to the site of 3′ end endonucleolytic processing of L-strand RNA precursor, spanning tRNASer(UCN) and ND6 mRNA. Thus, the A7445C or A7445T mutation may also cause a defect in the processing of the L-strand RNA precursor, thus causing mitochondrial dysfunctions. Furthermore, the occurrence of the mutations at position 7445 in these genetically unrelated subjects affected by hearing impairment strongly indicates that mutations at the position 7445 are involved in the pathogenesis of hearing impairment.
[Hearing Loss May Be Associated with the Novel Mitochondrial Trna(asp) A7551G Mutation in a Chinese Family].

Yue Wu,Ling-zhi Liang,Hong-li Xiao,Ya-ling Yang,Xiao Yu,Jing Zheng,Fang,Bin-jiao Zheng,Xiao-wen Tang,Long-jin Jin,Min-xin Guan

DOI: https://doi.org/10.3760/cma.j.issn.1673-0860.2013.12.003

2013-01-01

Abstract:OBJECTIVE:We reported here the clinical and genetic evaluations as well as mutational analysis of mitochondrial DNA(mtDNA) in a Chinese family with maternally transmitted non-syndromic hearing loss and investigated the influence of the mitochondrial tRNA(Asp) A7551G mutation to the phenotypic manifestation of the deafness.METHODS:One Chinese Han pedigrees of maternally transmitted nonsyndromic hearing loss were collected. The proband and family members underwent clinical, genetic, and molecular evaluations, such as audiological examinations, mutational analysis of mitochondrial genome and mutational analysis of GJB2 gene.RESULTS:Six people of this pedigree suffered from hearing loss, including four matrilineal members, and others did not have significant clinical abnormalities. Sequence analysis of the complete mitochondrial genome in the proband showed that there were 28 mtDNA polymorphisms belonging to East -Asian haplogroup A4.In addition to the A7551G homogeneity mutation, there were no other functionally significant variants found in this family. The A7551G mutation located immediately at the three prime end to the anticodon, corresponding with the conventional position 37 of tRNA(Asp), and its' CI value was 100% compared with other 15 primate species. The A7551G mutation was absent in other Chinese controls. The mutations on GJB2 were detected by direct sequence analysis,GJB2 235delC and 299delAT which was associated with hearing loss were found in the genomic DNA of the proband and some matrilineal members. Clinical evaluation showed a variable phenotype of severity, age-at-onset and audiometric configuration of hearing loss in the matrilineal relatives in these families.CONCLUSIONS:The A7551G mutation may modify the secondary structure of the tRNA, and affect the stabilization of tRNA(Asp), produce non-normal functional tRNA(Asp) ultimately. And it may cause the phenotypic manifestation of the deafness that associated with A7551G mutation. Therefore, the mitochondrial tRNA(Asp) A7551G mutation may be a new mitochondrial mutation for hearing loss.
Clinical and Molecular Analysis of a Four-Generation Chinese Family with Aminoglycoside-Induced and Nonsyndromic Hearing Loss Associated with the Mitochondrial 12S Rrna C1494T Mutation

QJ Wang,QZ Li,DY Han,YL Zhao,LD Zhao,YP Qian,H Yuan,RH Li,SQ Zhai,WY Young,MX Guan

DOI: https://doi.org/10.1016/j.bbrc.2005.12.045

IF: 3.1

2005-01-01

Biochemical and Biophysical Research Communications

Abstract:We report here the clinical, genetic, and molecular characterization of a four-generation Chinese family with aminoglycoside-induced and nonsyndromic hearing loss. Five of nine matrilineal relatives had aminoglycoside-induced hearing loss. These matrilineal relatives exhibited variable severity and audiometric configuration of hearing impairment, despite sharing some common features: being bilateral and having sensorineural hearing impairment. Sequence analysis of mitochondrial DNA (mtDNA) in the pedigree identified 16 variants and the homoplasmic 12S rRNA C1494T mutation, which was associated with hearing loss in the other large Chinese family. In fact, the occurrence of the C1494T mutation in these genetically unrelated pedigrees affected by hearing impairment strongly indicated that this mutation is involved in the pathogenesis of aminoglycoside-induced and nonsyndromic hearing loss. However, incomplete penetrance of hearing loss indicated that the C1494T mutation itself is not sufficient to produce a clinical phenotype but requires the involvement of modifier factors for the phenotypic expression. Those mtDNA variants, showing no evolutional conservation, may not have a potential modifying role in the pathogenesis of the C1494T mutation. However, nuclear background seems to contribute to the phenotypic variability of matrilineal relatives in this family. Furthermore, aminoglycosides modulate the expressivity and penetrance of deafness associated with the C1494T mutation in this family.
The ND4 G11696A Mutation May Influence the Phenotypic Manifestation of the Deafness-Associated 12S Rrna A1555G Mutation in a Four-Generation Chinese Family.

Zhisu Liao,Jianyue Zhao,Yi Zhu,Li Yang,Aifen Yang,Dongmei Sun,Zhongnong Zhao,Xinjian Wang,Zhihua Tao,Xiaowen Tang,Jindan Wang,Minqiang Guan,Jiafu Chen,Zhiyuan Li,Jianxin Lu,Min-Xin Guan

DOI: https://doi.org/10.1016/j.bbrc.2007.08.034

2007-01-01

Abstract:We report here the clinical, genetic and molecular characterization of a large Han Chinese family with aminoglycoside-induced and nonsyndromic hearing loss. The penetrance of hearing loss (affected matrilineal relatives/total matrilineal relatives) in this pedigree was 53%, when aminoglycoside-induced deafness was included. When the effect of aminoglycosides was excluded, the penetrance of hearing loss in this pedigree was 42%. These matrilineal relatives exhibited a wide range of severity of hearing loss, varying from profound to normal hearing. Furthermore, these affected matrilineal relatives shared some common features: bilateral hearing loss of high frequencies and symmetries. Sequence analysis of mitochondrial DNA (mtDNA) in the pedigree identified the homoplasmic 12S rRNA A1555G mutation and other 35 variants belonging to Eastern Asian haplogroup D4. Of these, the V313I (G11696A) mutation in ND4 was associated with vision loss. However, the extremely low penetrance of visual loss, and the mild biochemical defect and the presence of one/167 Chinese controls indicted that the G11696A mutation is itself not sufficient to produce a clinical phenotype. Thus, the G11696A mutation may act in synergy with the primary deafness-associated 12S rRNA A1555G mutation in this Chinese family, thereby increasing the penetrance and expressivity of hearing loss in this Chinese pedigree.
The genetic analysis of patients with non-syndrome deafness come from twenty-two families in Yuyao, Zhe-jiang province

Guanghua PENG,Hui WANG,Juan YAO,Wenlu FAN,Xiaowen TANG,Binjiao ZHENG,Ling XUE,Jianxin LYU,Minxin GUAN

DOI: https://doi.org/10.3969/j.issn.2095-9400.2016.10.002

2016-01-01

Abstract:Objective: To explore the clinical, genetic and molecular characteristics of twenty-two families with non-syndrome deafness in Yuyao area. This study focused on analyzing mutations of mitochondrial gene and coding sequence of GJB2, GJB3, GJB6 gene.Methods: The samples were 33 patients with non-syndrome deaf-ness come from 22 families in YuYao People’s hospital, and 254 cases with normal hearing. DNA were extracted out from peripheral blood of all subjects. All samples’ GJB2, GJB3 and GJB6 gene encoding region and mito-chondrial gene were analyzed by direct sequencing, audiological examination, genetic testing for deafness and pedigree data.Results: The sequencing results revealed that 4 families carried GJB2 235delC mutation, 2 fami-lies carried GJB2 compound heterozygous mutations accounted for 27.3% and 3 families carried mitochondrial 12S rRNA A1555G accounted for 13.6% in the 22 families with non-syndrome deafness. All families without pathogenic mutations in the GJB3 and GJB6 encoding region. According to clinical data, 6 families with GJB2 gene mutations and 3 families with 1555A>G mutations had different levels in hearing loss, age of onset, and the rate of hearing loss.Conclusion: GJB2 and mitochondrial 12S rRNA 1555A>G gene mutation are the main genetic inheritance for the patients with non-syndrome deafness in Yuyao area, there may also be other unknown genes or environmental factors to coordinated with GJB2 gene and mitochondrial 12S rRNA gene co-modulate the variable penetrance and expressivity of deafness.
Audiological and Genetic Studies on Large Families with Non-Syndromic Deafness

Xue Z. Liu,Xiao M. Ouyang,Li L. Du,Xiao M. Ke,Xing K. Pu,Chuan Y. Linag,Yu He Liu,Shi Xi Liu,Min-Xin Guan,Simon Angeli,Denise Yan

DOI: https://doi.org/10.1080/16513860802393416

2008-01-01

Audiological Medicine

Abstract:Recent progress in gene identification for non-syndromic deafness demonstrates the efficacy of using a large family approach. To assess if clinical and genetic heterogeneity exists in families with non-syndromic hearing impairment we have identified five large Chinese families suitable for investigating clinical and genetic heterogeneity. Five Chinese families spanning 5–6 generations and comprising 48 to 172 members were identified. The auditory phenotype was investigated with pure tone audiometry and DPOAEs. Age at onset of hearing loss was compared between generations by using life-table analysis and the Wilcoxon test in a family. All statistical analyses were performed using the SAS statistical package. Screening for GJB2 and mitochondrial mutations was performed. Two families showing maternal inheritance were found to have the mitDNA A1555G mutation. Subjects with the A1555G mutation exhibit a normal to profound, progressive deafness. Anticipation of the hearing loss was observed in one of these two families. The other three families are segregating for a late onset form of progressive hearing loss with normal vestibular function. DPOAEs from a group of possible gene carriers with normal audiograms in two families have shown a substantial difference from that of controls. Our data show the existence of clinical and genetic heterogeneity in the five large Chinese deaf families. Marked differences in severity of hearing loss, along with a lack of exposure to aminoglycosides and the presence of anticipation in the mitDNA deafness suggest the presence of a modifier. DPOAEs may be a sensitive test for a subclinical change in carriers. Identification of gene(s) for deafness should allow us to better understand the molecular basis of deafness and to improve patient care.
Mitochondrial ND5 T12338C, Trna(cys) T5802C, and Trna(thr) G15927A Variants May Have a Modifying Role in the Phenotypic Manifestation of Deafness-Associated 12S Rrna A1555G Mutation in Three Han Chinese Pedigrees.

Bobei Chen,Dongmei Sun,Li Yang,Chuqin Zhang,Affen Yang,Yi Zhu,Jianyue Zhao,Yingying Chen,Minqiang Guan,Xinjian Wang,Ronghua Li,Xiaowen Tang,Jindan Wang,Zhihua Tao,Jianxin Lu,Min-Xin Guan

DOI: https://doi.org/10.1002/ajmg.a.32285

2008-01-01

American Journal of Medical Genetics Part A

Abstract:We report here on the clinical, genetic, and molecular characterization of three Han Chinese pedigrees with aminoglycoside-induced and nonsyndromic hearing loss. Clinical evaluation revealed the variable phenotype of hearing impairment including severity, age-at-onset, audiometric configuration in these subjects. The penetrance of hearing loss in WZD8, WZD9, and WZD10 pedigrees were 46%, 46%, and 50%, respectively, when aminoglycoside-induced deafness was included. When the effect of aminoglycosides was excluded, the penetrance of hearing loss in these pedigrees were 23%, 31%, and 37.5%, respectively. Mutational analysis of the complete mitochondrial genomes showed the homoplasmic A1555G mutation and distinct sets of mitochondrial DNA variants belonging to haplogroups D4b2b, B5b1, and F2, respectively. Of these, the tRNA(Cys) T5802C, tRNA(Thr) A15924C, and ND5 T12338C variants are of special interest as these variants occur at positions which are highly evolutionarily conserved nucleotides of tRNAs or amino acid of polypeptide. These homoplasmic mtDNA variants were absent among 156 unrelated Chinese controls. The T5802C and G15927A variants disrupted a highly conserved A-U or C-G base-pairing at the anticodon-stem of tRNA(Cys) or tRNA(Thr), while the ND5 T12338C mutation resulted in the replacement of the translation-initiating methionine with a threonine, and also located in two nucleotides adjacent to the 3' end of the tRNA(Leu(CUN)). Thus, mitochondrial dysfunctions, caused by the A1555G mutation, would be worsened by these mtDNA variants. Therefore, these mtDNA mutations may have a potential modifier role in increasing the penetrance and expressivity of the deafness-associated 12S rRNA A1555G mutation in those Chinese pedigrees.
A Novel Recessive Truncating Mutation in Myo15a Causing Prelingual Sensorineural Hearing Loss

Wei Li,Luo Guo,Yu Li,Qianru Wu,Qingzhong Li,Huawei Li,Chunfu Dai

DOI: https://doi.org/10.1016/j.ijporl.2015.12.013

IF: 1.626

2016-01-01

International Journal of Pediatric Otorhinolaryngology

Abstract:Hearing loss (HL) is one of the most common human defects which affects millions of people globally. The identification of deafness-related genes or loci may facilitate basic and clinical translational research on this disorder. Here, we investigated a Chinese family with autosomal recessive non-syndromic hearing impairment. Using targeted massively parallel sequencing, we identified a novel homozygous mutation, c.3525_3526insA and p.Q1175fsX1188 (NM_016239), in exon 2 of MYO15A. Sanger sequencing confirmed that affected siblings were homozygous for the mutation, whereas both normal hearing parents were heterozygous. The mutation was absent in 96 healthy controls and public databases. The insertion leads to a frameshift and a truncated form of the protein, resulting in the pathogenic effect of hearing loss for the patients. Mutations in exon 2 of MYO15A may cause a less severe phenotype, facilitating the rapid identification of mutations in exon 2 among the 66 exons when linkage of less severe hearing loss to Deafness, Autosomal Recessive 3 (DFNB3) is detected. Our data provide additional molecular information for establishing a better genotype–phenotype understanding of DFNB3.
Exome Sequencing Identifies a Novel Frameshift Mutation Ofmyo6as the Cause of Autosomal Dominant Nonsyndromic Hearing Loss in a Chinese Family

Jing Cheng,Xueya Zhou,Yu Lu,Jing Chen,Bing Han,Yuhua Zhu,Liyang Liu,Kwong-Wai Choy,Dongyi Han,Pak C. Sham,Michael Q. Zhang,Xuegong Zhang,Huijun Yuan

DOI: https://doi.org/10.1111/ahg.12084

2014-01-01

Annals of Human Genetics

Abstract:Autosomal dominant types of nonsyndromic hearing loss (ADNSHL) are typically postlingual in onset and progressive. High genetic heterogeneity, late onset age, and possible confounding due to nongenetic factors hinder the timely molecular diagnoses for most patients. In this study, exome sequencing was applied to investigate a large Chinese family segregating ADNSHL in which we initially failed to find strong evidence of linkage to any locus by whole-genome linkage analysis. Two affected family members were selected for sequencing. We identified two novel mutations disrupting known ADNSHL genes and shared by the sequenced samples: c.328C>A in COCH (DFNA9) resulting in a p.Q110K substitution and a deletion c. 2814_2815delAA in MYO6 (DFNA22) causing a frameshift alteration p.R939Tfs*2. The pathogenicity of novel coding variants in ADNSHL genes was carefully evaluated by analysis of co-segregation with phenotype in the pedigree and in light of established genotype-phenotype correlations. The frameshift deletion in MYO6 was confirmed as the causative variant for this pedigree, whereas the missense mutation in COCH had no clinical significance. The results allowed us to retrospectively identify the phenocopy in one patient that contributed to the negative finding in the linkage scan. Our clinical data also supported the emerging genotype-phenotype correlation for DFNA22.
Characterization of a novel MYO3A missense mutation associated with a dominant form of late onset hearing loss

Vitor G L Dantas,Manmeet H Raval,Angela Ballesteros,Runjia Cui,Laura K Gunther,Guilherme L Yamamoto,Leandro Ucela Alves,André Silva Bueno,Karina Lezirovitz,Sulene Pirana,Beatriz C A Mendes,Christopher M Yengo,Bechara Kachar,Regina C Mingroni-Netto

DOI: https://doi.org/10.1038/s41598-018-26818-2

2018-06-07

Abstract:Whole-exome sequencing of samples from affected members of two unrelated families with late-onset non-syndromic hearing loss revealed a novel mutation (c.2090 T > G; NM_017433) in MYO3A. The mutation was confirmed in 36 affected individuals, showing autosomal dominant inheritance. The mutation alters a single residue (L697W or p.Leu697Trp) in the motor domain of the stereocilia protein MYO3A, leading to a reduction in ATPase activity, motility, and an increase in actin affinity. MYO3A-L697W showed reduced filopodial actin protrusion initiation in COS7 cells, and a predominant tipward accumulation at filopodia and stereocilia when coexpressed with wild-type MYO3A and espin-1, an actin-regulatory MYO3A cargo. The combined higher actin affinity and duty ratio of the mutant myosin cause increased retention time at stereocilia tips, resulting in the displacement of the wild-type MYO3A protein, which may impact cargo transport, stereocilia length, and mechanotransduction. The dominant negative effect of the altered myosin function explains the dominant inheritance of deafness.
Novel missense mutations in MYO7A underlying postlingual high- or low-frequency non-syndromic hearing impairment in two large families from China

Yi Sun,Jing Chen,Hanjun Sun,Jing Cheng,Jianzhong Li,Yu Lu,Yanping Lu,Zhanguo Jin,Yuhua Zhu,Xiaomei Ouyang,Denise Yan,Pu Dai,Dongyi Han,Weiyan Yang,Rongguang Wang,Xuezhong Liu,Huijun Yuan

DOI: https://doi.org/10.1038/jhg.2010.147

2010-01-01

Journal of Human Genetics

Abstract:The myosin VIIA ( MYO7A ) gene encodes a protein classified as an unconventional myosin. Mutations within MYO7A can lead to both syndromic and non-syndromic hearing impairment in humans. Among different mutations reported in MYO7A , only five led to non-syndromic sensorineural deafness autosomal dominant type 11 (DFNA11). Here, we present the clinical, genetic and molecular characteristics of two large Chinese DFNA11 families with either high- or low-frequency hearing loss. Affected individuals of family DX-J033 have a sloping audiogram at young ages with high frequency are most affected. With increasing age, all test frequencies are affected. Affected members of family HB-S037 present with an ascending audiogram affecting low frequencies at young ages, and then all frequencies are involved with increasing age. Genome-wide linkage analysis mapped the disease loci within the DFNA11 interval in both families. DNA sequencing of MYO7A revealed two novel nucleotide variations, c.652G>A (p.D218N) and c.2011G>A (p.G671S), in the two families. It is for the first time that the mutations identified in MYO7A in the present study are being implicated in DFNA11 in a Chinese population. For the first time, we tested electrocochleography (ECochG) in a DFNA11 family with low-frequency hearing loss. We speculate that the low-frequency sensorineural hearing loss in this DFNA11 family was not associated with endolymphatic hydrops.
Novel compound heterozygous mutations in the MYO15A gene in autosomal recessive hearing loss identified by whole-exome sequencing

Xue Gao,Qing-yan Zhu,Yue-Shuai Song,Guo-Jian Wang,Yong-Yi Yuan,Feng Xin,Sha-Sha Huang,Dong-Yang Kang,Ming-Yu Han,Li-ping Guan,Jian-guo Zhang,Pu Dai

DOI: https://doi.org/10.1186/1479-5876-11-284

IF: 8.44

2013-11-09

Journal of Translational Medicine

Abstract:Abstract Background Inherited genetic defects play an important role in congenital hearing loss, contributing to about 60% of deafness occurring in infants. Hereditary nonsyndromic hearing loss is highly heterogeneous, and most patients with a presumed genetic etiology lack a specific molecular diagnosis. Methods By whole exome sequencing, we identified responsible gene of family 4794 with autosomal recessively nonsyndromic hearing loss (ARNSHL). We also used DNA from 56 Chinese familial patients with ARNSHL (autosomal recessive nonsyndromic hearing loss) and 108 ethnicity-matched negative samples to perform extended variants analysis. Results We identified MYO15A c.IVS25 + 3G > A and c.8375 T > C (p.V2792A) as the disease-causing mutations. Both mutations co-segregated with hearing loss in family 4794, but were absent in the 56 index patients and 108 ethnicity-matched controls. Conclusions Our results demonstrated that the hearing loss of family 4794 was caused by novel compound heterozygous mutations in MYO15A .

medicine, research & experimental
Novel cis compound heterozygous variants in MYO6 causes early onset of non-syndromic hearing loss in a Chinese family

Haiting Ji,Lichun Zhang,Hafiz Muhammad Jafar Hussain,Ayesha Aftab,Huiqian Yu,Min Xiao

DOI: https://doi.org/10.3389/fgene.2023.1275633

IF: 3.7

2024-01-11

Frontiers in Genetics

Abstract:Background: Mutations in the MYO6 gene have been associated with both autosomal dominant non-syndromic hearing loss (ADNSHL) and autosomal recessive non-syndromic hearing loss (ARNSHL), with a cumulative identification of 125 pathogenic variants. To investigate the underlying genetic factor within a Chinese family affected with heriditary hearing loss, prompted the utilization of high-throughput sequencing. Method: A detailed clinical investigation was performed. Genetic testing was performed by using target panel sequencing, and Sanger sequencing. Targeted sequencing identified the variants and Sanger sequencing was employed to validate segregation of the identified variants within family. Additionally, bioinformatics analysis was performed to strengthen our findings. Results: Clinical investigation revealed the family members were affected by progressive and sensorineural hearing loss with an onset around 8–10 years old. Furthermore, genetic testing identified novel MYO6 variants, c.[2377T>G; 2382G>T] p.[Trp793Gly; Lys794Asn], positioned in a cis pattern, as plausible pathogenic contributors to early-onset hearing loss characterized by a severe and progressive course. Moreover, bioinformatics analysis showd disruptin in hydrogen bonding of mutant amino acids with interactive amino acids. Conclusion: Our research uncovered a relationship between mutations in the MYO6 gene and non-syndromic hearing loss. We identified two variants, c.[2377T>G; 2382G>T] p.[Trp793Gly; Lys794Asn] in MYO6 as strong candidates responsible for the observed progressive hereditary hearing loss. This study not only adds to our knowledge about hearing problems related to MYO6 but also reveals the presence of monogenic compound heterozygosity. Our study will provide a new sight for genetic diagnosis in such patients and their management for future use.

genetics & heredity

Current and future treatment modalities for hepatocellular carcinoma.

Identification of a Novel Homozygous Mutation in the MYO15A Gene in a Kazakh Family with Non-Syndromic Hearing Loss

A Novel Mutation Located in the N-Terminal Domain of MYO15A Caused Sensorineural Hearing Loss.

Maternally inherited hearing loss is associated with the novel mitochondrial tRNASer(UCN) 7505T>C mutation in a Han Chinese family

Clinical Evaluation And Sequence Analysis Of The Complete Mitochondrial Genome Of Three Chinese Patients With Hearing Impairment Associated With The 12s Rrna T1095c Mutation

Cosegregation of C-Insertion at Position 961 with the A1555g Mutation of the Mitochondrial 12s Rrna Gene in A Large Chinese Family with Maternally Inherited Hearing Loss

Maternally Inherited Aminoglycoside-Induced and Nonsyndromic Hearing Loss is Associated with the 12S Rrna C1494T Mutation in Three Han Chinese Pedigrees.

Extremely Low Penetrance of Deafness Associated with the Mitochondrial 12S Rrna T1095C Mutation in Three Chinese Families.

Mutations at position 7445 in the precursor of mitochondrial tRNASer(UCN) gene in three maternal Chinese pedigrees with sensorineural hearing loss

[Hearing Loss May Be Associated with the Novel Mitochondrial Trna(asp) A7551G Mutation in a Chinese Family].

Clinical and Molecular Analysis of a Four-Generation Chinese Family with Aminoglycoside-Induced and Nonsyndromic Hearing Loss Associated with the Mitochondrial 12S Rrna C1494T Mutation

The ND4 G11696A Mutation May Influence the Phenotypic Manifestation of the Deafness-Associated 12S Rrna A1555G Mutation in a Four-Generation Chinese Family.

The genetic analysis of patients with non-syndrome deafness come from twenty-two families in Yuyao, Zhe-jiang province

Audiological and Genetic Studies on Large Families with Non-Syndromic Deafness

Mitochondrial ND5 T12338C, Trna(cys) T5802C, and Trna(thr) G15927A Variants May Have a Modifying Role in the Phenotypic Manifestation of Deafness-Associated 12S Rrna A1555G Mutation in Three Han Chinese Pedigrees.

A Novel Recessive Truncating Mutation in Myo15a Causing Prelingual Sensorineural Hearing Loss

Exome Sequencing Identifies a Novel Frameshift Mutation Ofmyo6as the Cause of Autosomal Dominant Nonsyndromic Hearing Loss in a Chinese Family

Characterization of a novel MYO3A missense mutation associated with a dominant form of late onset hearing loss

Novel missense mutations in MYO7A underlying postlingual high- or low-frequency non-syndromic hearing impairment in two large families from China

Novel compound heterozygous mutations in the MYO15A gene in autosomal recessive hearing loss identified by whole-exome sequencing

Novel cis compound heterozygous variants in MYO6 causes early onset of non-syndromic hearing loss in a Chinese family